Elevated Serum SIRT2 Is Associated With Rapid Progression and Cognitive Impairment in Amyotrophic Lateral Sclerosis
Muscle & Nerve · 2026
DOI: 10.1002/mus.70162 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2026. Verfasst von Jun Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Research Institute of Neuromuscular and Neurodegenerative Disease, Shandong Univ…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Sirtuin 2, Cognitive Dysfunction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: the China postdoctoral science foundation, National Natural Science Foundation of China, Key R&D Program of Shandong Province, China.
Abstract (Originalsprache)
Introduction/Aims Amyotrophic lateral sclerosis (ALS) lacks reliable biomarkers to predict disease trajectories or guide therapeutic strategies. Sirtuin 2 (SIRT2), a NAD+‐dependent deacetylase implicated in cytoskeletal destabilization and neuroinflammatory pathways in preclinical ALS models, represents a promising yet unvalidated biomarker candidate. We aimed to translate preclinical findings by validating SIRT2's role in ALS.
Methods
A cross‐sectional cohort study was conducted, comparing serum SIRT2 levels, measured via enzyme‐linked immunosorbent assay (ELISA), between 182 ALS patients and 65 healthy controls. Clinical progression rates were derived from the ALS Functional Rating Scale‐Revised (ALSFRS‐R), and cognitive function was assessed using the Mini–Mental State Examination (MMSE) and Edinburgh Cognitive and Behavioral ALS Screen (ECAS).
Results
SIRT2 levels were significantly elevated in ALS patients versus controls, though diagnostic accuracy was modest (AUC = 0.620). Furthermore, SIRT2 levels showed a weak but significant positive correlation with disease progression rate ( r = 0.182, p = 0.014) and inverse correlations with cognitive scores on both MMSE ( r = −0.250, p = 0.032) and ECAS ( r = −0.286, p = 0.031). Notably, SIRT2 demonstrated a limited but detectable ability to stratify patients into fast‐ and slow‐progressing subgroups (AUC = 0.635).
Discussion
These findings provide preliminary clinical evidence linking elevated serum SIRT2 to disease progression and cognitive impairment in ALS, thereby supporting its role in disease heterogeneity. This work lends clinical support to preclinical insights, suggesting SIRT2 may aid in prognosis prediction and may represent a potential therapeutic target, necessitating further studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Qilu Hospital, Cheeloo College of Medicine, Research Institute of Neuromuscular and Neurodegenerative Disease, Shandong University, Jinan, China.
- School of Nursing and Rehabilitation, Cheeloo College of Medicine, Shandong University, Jinan, China.
ORCID-Profile: Jun Zhu
Förderung
- the China postdoctoral science foundation
- National Natural Science Foundation of China
- Key R&D Program of Shandong Province, China
- Yantu Neuroscience Specialized Research Fund Project
Zitieren
APA
Zhu, J., Wen, T., Gao, N., Wu, B., Ma, M., Sun, X., Liu, F., Lin, P., & Liu, S. (2026). Elevated Serum SIRT2 Is Associated With Rapid Progression and Cognitive Impairment in Amyotrophic Lateral Sclerosis. Muscle & Nerve. https://doi.org/10.1002/mus.70162
Vancouver
Zhu J, Wen T, Gao N, Wu B, Ma M, Sun X, et al. Elevated Serum SIRT2 Is Associated With Rapid Progression and Cognitive Impairment in Amyotrophic Lateral Sclerosis. Muscle & Nerve. 2026. doi:10.1002/mus.70162
BibTeX
@article{Zhu2026,
author = {Zhu, Jun and Wen, Tianrui and Gao, Ninglu and Wu, Bin and Ma, Mingjie and Sun, Xiaohan and Liu, Fuchen and Lin, Pengfei and Liu, Shuangwu},
title = {Elevated Serum SIRT2 Is Associated With Rapid Progression and Cognitive Impairment in Amyotrophic Lateral Sclerosis},
journal = {Muscle & Nerve},
year = {2026},
doi = {10.1002/mus.70162}
}
EUVIMED